Concepedia

Xinyi Dai

XD

Statistics

Publications

5

Citations

66

H-Index

5

Active since

2019

Affiliations

Nanjing University of Chinese Medicine(Current)

Xinyi Dai is an author at Nanjing University of Chinese Medicine specializing in oncology, anticancer prodrug design, and liver disease.

ORCID

Publications per year

2019–2025

5

Publications

5

Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma

Shuo Wu, Xinyi Dai, Dielai Xie · Frontiers in Genetics · 2019 · 16 citations · Full text

, , +17

Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD)

Xinyi Dai, Guowei Zhou, Luzhou Xu · PLoS ONE · 2022 · 14 citations · Full text

, , +16

SLC34A2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer

Yi Yang, Jiang Wu, Xiaofeng Yu et al. · Pathology - Research and Practice · 2021 · 13 citations · Full text

, , +17

The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy

Luzhou Xu, Lei Zhu, Kai Zheng et al. · Journal of Materials Chemistry B · 2021 · 12 citations

, , +15

ROS-responsive oridonin and dihydroartemisinin hetero-polymeric prodrug NPs for potentiating ferroptosis in gastric cancer by disrupting redox balance

Luzhou Xu, Yanqin Hu, Xinyi Dai et al. · Colloids and Surfaces B Biointerfaces · 2025 · 11 citations

, , +17

1–5 of 5